Pediatrix Medical Group (NYSE:MD) Reaches New 12-Month High - Here's What Happened

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) reached a new 52-week high on Friday . The company traded as high as $12.99 and last traded at $12.91, with a volume of 352342 shares changing hands. The stock had previously closed at $12.67.

Wall Street Analyst Weigh In

MD has been the topic of several recent analyst reports. UBS Group boosted their target price on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a "neutral" rating in a report on Friday, August 9th. StockNews.com raised Pediatrix Medical Group from a "sell" rating to a "hold" rating in a report on Wednesday, August 7th. Jefferies Financial Group raised Pediatrix Medical Group from a "hold" rating to a "buy" rating and boosted their target price for the stock from $8.00 to $14.00 in a report on Thursday, September 26th. Finally, Truist Financial boosted their target price on Pediatrix Medical Group from $10.00 to $13.00 and gave the stock a "hold" rating in a report on Monday, October 7th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $10.90.

Pediatrix Medical Group Stock Up 0.7 %

The firm's 50-day simple moving average is $11.15 and its 200 day simple moving average is $9.16. The company has a market cap of $1.10 billion, a P/E ratio of -4.21, a PEG ratio of 1.91 and a beta of 1.56. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38 and a current ratio of 1.38.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.31 by $0.03. The business had revenue of $504.30 million during the quarter, compared to analysts' expectations of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The firm's quarterly revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.37 EPS. On average, research analysts forecast that Pediatrix Medical Group, Inc. will post 1.19 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO James D. Swift sold 11,100 shares of the firm's stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $10.79, for a total value of $119,769.00. Following the completion of the transaction, the chief executive officer now owns 170,001 shares in the company, valued at $1,834,310.79. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO James D. Swift sold 11,100 shares of the firm's stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $10.79, for a total value of $119,769.00. Following the completion of the transaction, the chief executive officer now owns 170,001 shares in the company, valued at $1,834,310.79. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Laura A. Linynsky sold 7,000 shares of the firm's stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total value of $78,120.00. Following the completion of the transaction, the director now owns 30,805 shares of the company's stock, valued at $343,783.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 68,100 shares of company stock worth $701,889 in the last quarter. Corporate insiders own 1.20% of the company's stock.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently bought and sold shares of MD. nVerses Capital LLC bought a new position in Pediatrix Medical Group during the second quarter worth about $31,000. Innealta Capital LLC acquired a new stake in Pediatrix Medical Group during the second quarter worth approximately $33,000. Nisa Investment Advisors LLC lifted its position in Pediatrix Medical Group by 47.2% during the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company's stock worth $36,000 after acquiring an additional 1,524 shares during the last quarter. Canada Pension Plan Investment Board acquired a new stake in Pediatrix Medical Group during the second quarter worth approximately $72,000. Finally, CWM LLC lifted its position in Pediatrix Medical Group by 134.0% during the third quarter. CWM LLC now owns 6,427 shares of the company's stock worth $74,000 after acquiring an additional 3,681 shares during the last quarter. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.